Effect of dipyridamole on transport and phosphorylation of thymidine and 3'-azido-3'-deoxythymidine in human monocyte/macrophages. 1990

G V Betageri, and J Szebeni, and K Hung, and S S Patel, and L M Wahl, and M Corcoran, and J N Weinstein
National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

Dipyridamole (DPM), a commonly used coronary vasodilator and antithrombotic drug, was shown recently to potentiate the antiviral effect of 3'-azido-3'-deoxythymidine (AZT) in HIV-1 infected human monocyte-derived macrophages (M/M) in vitro. We report in the present study that in uninfected M/M, DPM markedly inhibited cellular uptake of [3H]thymidine (dThd) and its incorporation into the nucleotide pools, particularly the dThd-triphosphate pool. In contrast, DPM did not affect cellular uptake and phosphorylation of [3H]AZT. Since dThd counteracts the phosphorylation and antiviral action of AZT, these findings support the hypothesis that the potentiation of the anti-HIV effect of AZT is due, at least in part, to differential inhibition of nucleoside salvage.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D013936 Thymidine A nucleoside in which THYMINE is linked to DEOXYRIBOSE. 2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

G V Betageri, and J Szebeni, and K Hung, and S S Patel, and L M Wahl, and M Corcoran, and J N Weinstein
May 1989, Proceedings of the National Academy of Sciences of the United States of America,
G V Betageri, and J Szebeni, and K Hung, and S S Patel, and L M Wahl, and M Corcoran, and J N Weinstein
January 1993, Oncology research,
G V Betageri, and J Szebeni, and K Hung, and S S Patel, and L M Wahl, and M Corcoran, and J N Weinstein
January 1991, Antimicrobial agents and chemotherapy,
G V Betageri, and J Szebeni, and K Hung, and S S Patel, and L M Wahl, and M Corcoran, and J N Weinstein
June 1992, The Journal of biological chemistry,
G V Betageri, and J Szebeni, and K Hung, and S S Patel, and L M Wahl, and M Corcoran, and J N Weinstein
January 1996, Chemotherapy,
G V Betageri, and J Szebeni, and K Hung, and S S Patel, and L M Wahl, and M Corcoran, and J N Weinstein
June 1993, Antimicrobial agents and chemotherapy,
G V Betageri, and J Szebeni, and K Hung, and S S Patel, and L M Wahl, and M Corcoran, and J N Weinstein
July 1995, Biochemical pharmacology,
G V Betageri, and J Szebeni, and K Hung, and S S Patel, and L M Wahl, and M Corcoran, and J N Weinstein
July 2006, Biochemical pharmacology,
G V Betageri, and J Szebeni, and K Hung, and S S Patel, and L M Wahl, and M Corcoran, and J N Weinstein
April 2006, Biochemical pharmacology,
G V Betageri, and J Szebeni, and K Hung, and S S Patel, and L M Wahl, and M Corcoran, and J N Weinstein
May 1996, Immunopharmacology and immunotoxicology,
Copied contents to your clipboard!